zolbetuximab
astellas
[]
we re exploring a potential approach in advanced #gastriccancer. see the latest results in claudin 18.2-positive, her2-negative locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma, shared this week at #gi23.
A pharma company dedicated to changing tomorrow by improving the health of people around the world. Tweets for U.S. audience. Guidelines: https://t.co/AJlgiDgp38